Linus Health, Inc.

Linus Health is a digital health company that develops AI-enabled cognitive assessment platforms for early detection and management of cognitive impairment and dementia. The company provides scientifically-validated digital cognitive testing solutions that integrate long-trusted neuropsychological assessments with advanced analytics to deliver actionable clinical insights. Linus Health's platform serves two primary market segments: healthcare delivery (primary care practices, medical centers, specialty neurology) and life sciences (clinical trials, research studies). The technology originated from 8+ years of R&D performed at MIT and Lahey Medical Center. The platform has been validated in over 150 peer-reviewed publications across journals including Neurology, Journal of Alzheimer's Disease, and Neuropsychologia, demonstrating sensitivity in detecting subtle cognitive impairment and associations with Alzheimer's biomarkers. The company targets the significant gap in cognitive care capacity—projected neurologist shortages of 19% by 2025—and the critical window for intervention, as Alzheimer's pathology can present 15-20 years before overt symptoms. Linus Health's digital assessment approach makes cognitive testing more accessible, practical, and efficient compared to traditional in-clinic methods. The platform is designed for integration across care settings and supports earlier detection workflows aligned with emerging biomarker-driven treatment paradigms. The company has received recognition including TIME Magazine Best Inventions and Fast Company Innovation by Design awards.